Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Cytomegalovirus Infection

Free Subscription Articles published in Transplantation Retrieve available abstracts of 35 articles: HTML format Text format

Single Articles

April 2018
1. SANTOS CAQ, Brennan DC
   Cytomegalovirus: a Guide for the Perplexed.
   Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002203.
   PubMed     Text format    
   
   
   March 2018
2. KOTTON CN, Kumar D, Caliendo AM, Huprikar S, et al
   The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.
   Transplantation. 2018 Mar 29. doi: 10.1097/TP.0000000000002191.
   PubMed     Text format     Abstract available
   
   
   
3. JACOBSEN MC, Manunta MDI, Pincott ES, Fenton M, et al
   Specific Immunity to Cytomegalovirus in Pediatric Cardiac Transplantation.
   Transplantation. 2018 Mar 5. doi: 10.1097/TP.0000000000002157.
   PubMed     Text format     Abstract available
   
   
   January 2018
4. CHAIYAPAK T, Borges K, Williams A, Banh T, et al
   Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients after Cessation of Antiviral Prophylaxis.
   Transplantation. 2018 Jan 26. doi: 10.1097/TP.0000000000002115.
   PubMed     Text format     Abstract available
   
   
   December 2017
5. LIU AW, Jutivorakool K, Fisher CE, Rakita RM, et al
   Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients.
   Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002029.
   PubMed     Text format     Abstract available
   
   
   November 2017
6. WITZKE O, Nitschke M, Bartels M, Wolters H, et al
   Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: Long-term results after 7 years of a randomized clinical trial.
   Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002024.
   PubMed     Text format     Abstract available
   
   
   August 2017
7. LODDING IP, Schultz HH, Jensen JU, Kirkby N, et al
   Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia.
   Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001927.
   PubMed     Text format     Abstract available
   
   
   June 2017
8. BALL S
   Aggregating Marginal Gains in Posttransplant CMV Risk Stratification.
   Transplantation. 2017 Jun 29. doi: 10.1097/TP.0000000000001869.
   PubMed     Text format    
   
   
   
9. SCHACHTNER T, Stein M, Reinke P
   CMV-specific T Cell Monitoring Offers Superior Risk Stratification of CMV-seronegative Kidney Transplant Recipients of a CMV-seropositive Donor.
   Transplantation. 2017 Jun 7. doi: 10.1097/TP.0000000000001825.
   PubMed     Text format     Abstract available
   
   
   February 2017
10. SANTOS AH JR, Casey MJ, Xuerong W, Womer KL, et al
    Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
    Transplantation. 2017;101:377-386.
    PubMed     Text format     Abstract available
    
    
    
11. DURAN-STRUUCK R, Sondermeijer HP, Buhler L, Alonso-Guallart P, et al
    Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
    Transplantation. 2017;101:274-283.
    PubMed     Text format     Abstract available
    
    
    January 2017
12. 
    Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation: Erratum.
    Transplantation. 2017;101:e40.
    PubMed     Text format    
    
    
    December 2016
13. MICHAELS MG, Humar A
    Cytomegalovirus in the Pediatric Transplant Recipient: where are we now?
    Transplantation. 2016 Dec 31. doi: 10.1097/TP.0000000000001627.
    PubMed     Text format    
    
    
    
14. ABATE D
    The First 90 Days: Temporary Effect of Alemtuzumab on CMV Immune Reconstitution.
    Transplantation. 2016.
    PubMed     Text format    
    
    
    November 2016
15. GE S, Karasyov A, Sinha A, Petrosyan A, et al
    Cytomegalovirus Immunity after Alemtuzumab Induction in Desensitized Kidney Transplant Patients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
16. NICASTRO E, Giovannozzi S, Stroppa P, Callegaro AP, et al
    Effectiveness of preemptive therapy for Cytomegalovirus disease in pediatric liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
17. AVERY RK, Arav-Boger R, Marr KA, Kraus E, et al
    Outcomes in Transplant Recipients Treated with Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    
18. FURUICHI M, Fujiwara T, Fukuda A, Kasahara M, et al
    Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    
19. FINE NM, Kushwaha SS
    RECENT ADVANCES IN MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR USE IN HEART AND LUNG TRANSPLANTATION.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
20. NATORI Y, Humar A, Husain S, Rotstein C, et al
    Recurrence of CMV Infection and the Effect of Prolonged Antivirals in Organ Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
21. LOLLINGA WT, de Wit RH, Rahbar A, Vasse GF, et al
    Human Cytomegalovirus-Encoded Receptor US28 Is Expressed in Renal Allografts and Facilitates Viral Spreading In Vitro.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    May 2016
22. QESARI M, Richter A, Ogonek J, Mischak-Weissinger E, et al
    Cytomegalovirus-Specific T Cells Isolated by IFN-gamma Secretion Assay Do Not Induce Significant Graft-Versus-Host Reactions In Vitro.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    March 2016
23. SCHULZ U, Solidoro P, Muller V, Szabo A, et al
    CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients.
    Transplantation. 2016;100 Suppl 3:S5-S10.
    PubMed     Text format     Abstract available
    
    
    
24. REA F, Potena L, Yonan N, Wagner F, et al
    Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.
    Transplantation. 2016;100 Suppl 3:S19-26.
    PubMed     Text format     Abstract available
    
    
    
25. CARBONE J
    The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV.
    Transplantation. 2016;100 Suppl 3:S11-8.
    PubMed     Text format     Abstract available
    
    
    
26. GROSSI P, Mohacsi P, Szabolcs Z, Potena L, et al
    Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.
    Transplantation. 2016;100 Suppl 3:S1-4.
    PubMed     Text format     Abstract available
    
    
    January 2016
27. WESESLINDTNER L, Gorzer I, Roedl K, Kung E, et al
    Intrapulmonary Human Cytomegalovirus Replication in Lung Transplant Recipients Is Associated With a Rise of CCL-18 and CCL-20 Chemokine Levels.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    
28. PARAJULI S, Muth BL, Turk JA, Astor BC, et al
    In Kidney Transplant Recipients With a Positive Virtual Crossmatch, High PRA was Associated With Lower Incidence of Viral Infections.
    Transplantation. 2016.
    PubMed     Text format     Abstract available
    
    
    
29. LIMAYE AP, La Rosa C, Longmate J, Diamond DJ, et al
    Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients.
    Transplantation. 2016;100:210-6.
    PubMed     Text format     Abstract available
    
    
    November 2015
30. PERALDI MN, Berrou J, Venot M, Chardiny V, et al
    Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer.
    Transplantation. 2015;99:2422-30.
    PubMed     Text format     Abstract available
    
    
    September 2015
31. CASTON JJ, Castells L, Varo E, Gomez MA, et al
    Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available
    
    
    August 2015
32. HOCKER B, Zencke S, Krupka K, Fichtner A, et al
    Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir.
    Transplantation. 2015.
    PubMed     Text format     Abstract available
    
    
    
33. NAGAI S, Mangus RS, Anderson E, Ekser B, et al
    Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation: A Single Center Experience With 210 Cases.
    Transplantation. 2015.
    PubMed     Text format     Abstract available
    
    
    July 2015
34. LIONAKI S, Altanis N, Papaxoinis K, Delladetsima I, et al
    A Cytomegalovirus-related Pseudotumor in the Colon of A Renal Transplant Recipient Shrunk by Antiviral Therapy.
    Transplantation. 2015;99:e46-7.
    PubMed     Text format    
    
    
    March 2015
35. VERGHESE PS, Schmeling DO, Knight JA, Matas AJ, et al
    The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
    Transplantation. 2015;99:602-8.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: